Home> Products> social outcomes

{ "products": [ { "_id": "69fedaef4a22f7e4d2047808", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "lithium carbonate 300 mg", "description": "Introduction to Lithium Carbonate 300 mg\n\nLithium Carbonate 300 mg is a widely prescribed medicine primarily used for the treatment and management of bipolar disorder and certain mental health conditions. It belongs to a group of medicines known as mood stabilizers and is highly effective in helping control mood swings, manic episodes, and emotional instability.\n\nLithium Carbonate 300 mg tablets are commonly recommended by psychiatrists and healthcare professionals for long-term mental health management. The medicine helps balance brain activity and reduces the intensity and frequency of mood fluctuations in patients suffering from bipolar disorder.\n\nFor pharmacies, hospitals, distributors, exporters, healthcare providers, and pharmaceutical buyers seeking a reliable psychiatric medicine, Lithium Carbonate 300 mg remains one of the most trusted and clinically established treatment options worldwide.\n\nWhat is Lithium Carbonate 300 mg?\n\nLithium Carbonate 300 mg is a prescription medication mainly used to treat bipolar disorder, particularly manic episodes. It may also be used in certain cases of depression and other psychiatric conditions as advised by healthcare professionals.\n\nThe medicine works by stabilizing mood and helping reduce abnormal brain activity associated with emotional and behavioral disturbances.\n\nLithium has been used for several decades in psychiatric treatment and continues to be considered one of the most effective mood stabilizers available in modern medicine.\n\nHow Does Lithium Carbonate 300 mg Work?\n\nLithium Carbonate works by affecting the levels of certain natural chemicals and neurotransmitters in the brain. It helps restore balance in brain signaling pathways responsible for mood regulation.\n\nThe medicine helps reduce excessive excitement in the brain and controls symptoms associated with mania such as:\n\nExtreme mood elevation\nHyperactivity\nAggressive behavior\nRacing thoughts\nImpulsive actions\n\nMood Stabilization→Reduced Manic Episodes\n\nRegular use under medical supervision helps patients maintain emotional balance and improve mental well-being over time.\n\nBenefits of Lithium Carbonate 300 mg\n\nLithium Carbonate 300 mg provides several important therapeutic and psychological benefits.\n\nHelps Stabilize Mood\n\nThe medicine is highly effective in controlling sudden mood swings and emotional instability.\n\nReduces Manic Episodes\n\nIt helps manage symptoms of mania, including excessive excitement and impulsive behavior.\n\nSupports Long-Term Mental Health Management\n\nLithium therapy is commonly used for long-term treatment to prevent relapse of bipolar disorder symptoms.\n\nImproves Emotional Balance\n\nPatients often experience improved emotional control and better daily functioning.\n\nHelps Prevent Recurrence\n\nContinuous therapy may reduce the frequency of future manic or depressive episodes.\n\nClinically Proven Treatment\n\nLithium remains one of the most established and scientifically supported mood stabilizers in psychiatry.\n\nKey Features of Lithium Carbonate 300 mg\nEffective Mood Stabilizer\n\nLithium Carbonate is recognized globally for bipolar disorder treatment.\n\nLong-Term Therapeutic Support\n\nSuitable for ongoing psychiatric care under medical guidance.\n\nOral Tablet Convenience\n\nEasy-to-administer tablet form supports patient compliance.\n\nReliable Psychiatric Medicine\n\nWidely prescribed by mental health professionals worldwide.\n\nSupports Better Quality of Life\n\nHelps patients maintain improved emotional and social functioning.\n\nUses of Lithium Carbonate 300 mg\n\nLithium Carbonate 300 mg is commonly prescribed for various psychiatric conditions.\n\nBipolar Disorder\n\nPrimarily used to control manic episodes and stabilize mood fluctuations.\n\nMania Management\n\nHelps reduce hyperactivity, agitation, and excessive emotional excitement.\n\nMaintenance Therapy\n\nUsed as long-term therapy to prevent recurrence of mood episodes.\n\nCertain Depressive Disorders\n\nIn some cases, healthcare professionals may prescribe it alongside antidepressants.\n\nWho Can Use Lithium Carbonate 300 mg?\n\nThe medicine may be recommended for:\n\nAdults diagnosed with bipolar disorder\nPatients experiencing manic episodes\nIndividuals requiring mood stabilization therapy\nPatients under psychiatric supervision\n\nTreatment should always be guided by a qualified healthcare provider.\n\nHow to Take Lithium Carbonate 300 mg\n\nPatients must strictly follow medical advice regarding dosage and duration.\n\nGeneral Administration Guidelines\nTake exactly as prescribed\nUsually taken with food to reduce stomach discomfort\nSwallow tablets with water\nMaintain adequate hydration during treatment\nTake doses at the same time daily\n\nNever stop the medicine suddenly without consulting a doctor.\n\nSide Effects of Lithium Carbonate 300 mg\n\nLike all medications, Lithium Carbonate may cause side effects in some individuals.\n\nCommon Side Effects\nIncreased thirst\nFrequent urination\nMild hand tremors\nNausea\nWeight gain\nFatigue\nDrowsiness\nSerious Side Effects\nSevere tremors\nConfusion\nMuscle weakness\nIrregular heartbeat\nSlurred speech\nVision disturbances\n\nImmediate medical attention is necessary if serious side effects occur.\n\nLithium Toxicity Warning\n\nLithium requires careful dose monitoring because excessive levels can become harmful.\n\nSigns of Lithium Toxicity\nSevere vomiting\nExtreme drowsiness\nLoss of coordination\nBlurred vision\nSevere tremors\nMental confusion\n\nPatients should undergo regular blood tests to monitor lithium levels and kidney function.\n\nPrecautions Before Using Lithium Carbonate 300 mg\n\nBefore starting treatment, patients should discuss their complete medical history with healthcare providers.\n\nInform Your Doctor If You Have:\nKidney disease\nHeart problems\nThyroid disorders\nDehydration\nEpilepsy\nPregnancy or breastfeeding concerns\nImportant Safety Measures\nMaintain proper fluid intake\nAvoid dehydration\nAttend regular medical checkups\nMonitor lithium blood levels regularly\nAvoid sudden dietary sodium changes\nDrug Interactions of Lithium Carbonate 300 mg\n\nLithium may interact with several medicines that affect its blood concentration.\n\nMedicines That May Interact\nDiuretics\nNSAID painkillers\nBlood pressure medicines\nAntidepressants\nAntipsychotic medicines\nCertain antibiotics\n\nAlways inform healthcare professionals about all medications and supplements being used.\n\nStorage Instructions\n\nTo preserve medicine quality:\n\nStore in a cool and dry place\nKeep away from direct sunlight\nProtect from moisture\nKeep out of reach of children\nWhy Choose Lithium Carbonate 300 mg?\n\nLithium Carbonate continues to be one of the most trusted psychiatric medicines because of its long-standing effectiveness and clinical reliability.\n\nProven Mood Stabilization\n\nExtensively used for bipolar disorder management worldwide.\n\nLong-Term Treatment Success\n\nHelps reduce recurrence of manic episodes effectively.\n\nWidely Recommended by Psychiatrists\n\nTrusted by mental health professionals for decades.\n\nCost-Effective Mental Health Therapy\n\nProvides reliable treatment support for long-term psychiatric care.\n\nBuying Guide for Lithium Carbonate 300 mg\n\nWhen purchasing Lithium Carbonate 300 mg tablets, buyers should consider the following factors.\n\nProduct Quality Standards\n\nSelect medicines manufactured under certified pharmaceutical facilities.\n\nReliable Manufacturer\n\nChoose trusted pharmaceutical companies known for psychiatric medicines.\n\nPackaging and Stability\n\nProper packaging ensures medicine safety and effectiveness.\n\nBulk Supply Availability\n\nHospitals, distributors, and exporters should verify consistent supply capability.\n\nRegulatory Compliance\n\nEnsure products meet applicable pharmaceutical regulations and documentation requirements.\n\nFrequently Asked Questions\nWhat is Lithium Carbonate 300 mg used for?\n\nIt is mainly used to treat bipolar disorder and manage manic episodes.\n\nIs Lithium Carbonate a mood stabilizer?\n\nYes, it is one of the most commonly prescribed mood stabilizers.\n\nCan Lithium Carbonate be used long term?\n\nYes, many patients use it for long-term management under medical supervision.\n\nDoes Lithium Carbonate require monitoring?\n\nYes, regular blood tests are necessary to monitor lithium levels and organ function.\n\nCan Lithium Carbonate cure bipolar disorder?\n\nNo, it does not cure bipolar disorder, but it helps control symptoms effectively.\n\nConclusion\n\nLithium Carbonate 300 mg is a highly effective and widely trusted psychiatric medicine used for the management of bipolar disorder and mood instability. Its proven ability to stabilize mood, reduce manic episodes, and support long-term emotional balance makes it a cornerstone treatment in psychiatric care.\n\nWith decades of clinical use, reliable therapeutic outcomes, and strong support in mental health management, Lithium Carbonate 300 mg remains a preferred choice for psychiatrists, healthcare providers, hospitals, pharmacies, and pharmaceutical buyers worldwide.", "price": 119.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2415, "imageuri": "https://productimages.withfloats.com/actual/69fedaf2d46c0b5bfc68b836.png", "tileimageuri": "https://productimages.withfloats.com/tile/69fedaf2d46c0b5bfc68b836.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-09T06:57:51.013Z", "updatedon": "2026-05-11T09:18:07.354Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lithium-carbonate-300-mg/2415", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELCARBONATE 300 SR", "category": "NEUROLOGY RANGE", "tags": [ "lithium carbonate 300 mg", "lithium carbonate 300 mg uses in hindi", "lithium carbonate 300 mg uses", "lithium carbonate 300", "lithium carbonate 300 mg tablet", "lithium carbonate 300 mg brand name", "lithium carbonate 300 mg side effects", "lithium carbonate 300 mg tablets", "what is lithium carbonate 300 mg used for", "lithium carbonate 300 mg tab", "lithium carbonate 300 mg reviews", "lithium carbonate 300 mg price", "side effects of lithium carbonate 300 mg", "lithium carbonate 300 mg cap" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69ce28ce7523e3729e781723", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "tiapride hydrochloride tablets", "description": "TIAPRADE 50 tablets, containing Tiapride Hydrochloride 50mg, offer targeted relief for behavioral disorders and movement issues. This atypical antipsychotic helps manage symptoms like agitation and dyskinesia effectively.\n\nProduct Description\nTIAPRADE 50 is a prescription medication featuring Tiapride Hydrochloride as its active ingredient, each tablet delivering precisely 50mg of this compound. Manufactured to high pharmaceutical standards, these tablets are designed for oral administration, typically taken with water after meals to enhance absorption and minimize stomach upset. Tiapride belongs to the class of selective dopamine D2 and D3 receptor antagonists, distinguishing it from typical antipsychotics by its lower risk of extrapyramidal side effects. This makes TIAPRADE 50 particularly suitable for vulnerable populations, including the elderly.\n\nThe tablets are compact, film-coated for easy swallowing, and come in blister packs that protect against moisture and light. As a non-sedating option in many cases, TIAPRADE 50 supports daily functioning without excessive drowsiness, aligning with modern psychiatric care needs. For SEO optimization targeting “Tiapride Hydrochloride Tablets” or “TIAPRADE 50 uses,” this product stands out for its versatility in treating neuropsychiatric conditions.\n\nKey Uses and Applications\nTIAPRADE 50 excels in managing a range of psychiatric and neurological conditions rooted in dopamine imbalance. Primarily, it treats schizophrenia by controlling negative symptoms such as social withdrawal, lack of emotion, and poor concentration, helping patients reintegrate into society.\n\nIt is highly effective for behavioral disorders, including agitation, aggression, and impulsivity, especially in elderly patients with dementia or alcohol withdrawal syndrome. Clinically, TIAPRADE 50 addresses dyskinesia—involuntary movements of limbs or face—often linked to Parkinson's disease or long-term antipsychotic use. Other applications include Tourette's syndrome, tics, chorea in Huntington's disease, and even acute alcohol dependence delirium tremens.\n\nIn hospital settings, such as during COVID-19-related agitation, TIAPRADE 50 has shown promise due to its favorable safety profile. Dosage typically starts at 100-200mg three times daily (2-4 tablets of TIAPRADE 50), adjustable up to 600mg/day based on severity, age, and response. Full effects may take 4-6 weeks, so consistent use under medical supervision is essential.\n\nHow TIAPRADE 50 Works\nTIAPRADE 50 modulates dopamine activity in the brain's limbic system, blocking overactive D2 receptors without strongly affecting other neurotransmitters like serotonin or histamine. This selective action reduces psychotic symptoms, calms agitation, and suppresses abnormal movements while preserving cognitive function.\n\nUnlike broader antipsychotics, Tiapride's mechanism minimizes motor side effects, making it ideal for long-term dyskinesia management. It stabilizes mood swings in mania or schizophrenia, promoting clearer thinking and emotional balance. Patients often report improved sleep patterns and reduced anxiety within days, though optimal benefits build gradually.\n\nFor “Tiapride Hydrochloride Tablets mechanism,” this targeted dopamine inhibition underpins its efficacy across disorders, supported by decades of clinical data.\n\nKey Benefits\nTIAPRADE 50 delivers multifaceted benefits, enhancing quality of life for those with psychiatric challenges.\n\nRapid Symptom Control: Quickly reduces agitation and aggression, vital for elderly care or acute episodes.\n\nLow Extrapyramidal Risk: Unlike older antipsychotics, it rarely causes stiffness or tremors, ideal for dyskinesia patients.\n\nElderly-Friendly: Mild sedation profile supports geriatric use without impairing mobility or cognition.\n\nVersatile for Comorbidities: Effective in alcohol withdrawal, tics, and schizophrenia, reducing polypharmacy needs.\n\nImproved Daily Functioning: Boosts social engagement, attention, and emotional expression in psychosis.\n\nStudies affirm its tolerability, with many patients tolerating doses up to 600 mg daily long-term. Benefits extend to headache relief in some neurological cases and better outcomes in Tourette's management.\n\nBenefit\tTarget Condition\tAdvantage Over Alternatives\nAgitation Reduction\tElderly Behavioral Disorders\tLess sedation than benzodiazepines \nDyskinesia Control\tParkinson's-Related\tMinimal motor worsening \nNegative Symptom Relief\tSchizophrenia\tPreserves cognition \nWithdrawal Support\tAlcohol Dependence\tSafer in delirium tremens \nPotential Side Effects\nWhile generally well-tolerated, TIAPRADE 50 may cause mild, transient side effects that resolve with time or dose adjustment.\n\nCommon effects include drowsiness, dizziness, headache, insomnia, fatigue, and agitation—often fading after the first week. Less frequent are tremor, increased salivation, vertigo, orthostatic hypotension (dizziness on standing), and emotional blunting.\n\nRarely, overdose risks low blood pressure, sedation, or convulsions; seek immediate help if suspected. Avoid abrupt cessation to prevent rebound symptoms. Most resolve without intervention, but persistent issues warrant medical review.\n\nContraindications and Precautions\nDo not use TIAPRADE 50 if you have prolactinoma, pheochromocytoma, severe kidney/liver disease, heart conditions, convulsions history, or allergies to Tiapride. It's contraindicated in pregnancy, breastfeeding, children under 15, and those with epilepsy.\n\nPrecautions include monitoring prolactin levels, blood pressure, and liver function. Avoid alcohol, as it amplifies sedation. Drive cautiously until the effects are known. Drug interactions with antihypertensives or CNS depressants require dose tweaks.\n\nDosage Guidelines\nStart with 50-100mg (1-2 TIAPRADE 50 tablets) three times daily, post-meals. Maximum 600mg/day for adults; elderly may need lower doses (300mg/day). Adjust per response, not exceeding 4-6 weeks without reassessment. Swallow whole; store below 30°C.\n\nConclusion\nTIAPRADE 50 (Tiapride Hydrochloride Tablets 50 mg) stands as a reliable, SEO-highlighted solution for agitation, dyskinesia, schizophrenia, and behavioral disorders, balancing efficacy with safety. Its dopamine-selective action delivers key benefits like symptom control and preserved function, outweighing manageable side effects for suitable patients. Consult your doctor to integrate TIAPRADE 50 into your care plan for optimal mental health outcomes—empowering calmer, more productive lives.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2362, "imageuri": "https://productimages.withfloats.com/actual/69ce28d0b438828e202fff3f.png", "tileimageuri": "https://productimages.withfloats.com/tile/69ce28d0b438828e202fff3f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-02T08:29:02.247Z", "updatedon": "2026-04-02T08:29:02.247Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tiapride-hydrochloride-tablets/2362", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TIAPRADE 50", "category": "NEUROLOGYRANGE", "tags": [ "tiapride hydrochloride tablets uses in hindi", "tiapride 50 mg tablets wholesale supplier", "tiapride tablet for anxiety and stress", "tiapride tablets india uses and price", "tiapride tablets for neurological disorders", "tiapride hydrochloride tablets 50 mg uses and side effects", "tiapride hydrochloride tablets b2b supplier" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69abcb9edc3b89f04c601e95", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Acamprosate Gastro Resistant 666mg", "description": "ACAMPURE 666 is a prescription medication containing Acamprosate Gastro-Resistant 666 mg, a medicine specifically designed to support individuals recovering from alcohol dependence. It is commonly used as part of a comprehensive treatment program that includes counseling, behavioral therapy, and lifestyle changes to help individuals maintain long-term sobriety.\n\nAlcohol dependence is a chronic condition that affects both the brain and behavior. Even after stopping alcohol consumption, many individuals continue to experience intense cravings and psychological discomfort that may lead to relapse. ACAMPURE 666 works by helping restore the natural chemical balance in the brain that becomes disrupted due to prolonged alcohol use.\n\nThe gastro-resistant formulation ensures that the medication passes through the stomach without breaking down and dissolves in the intestine, which improves absorption and reduces potential stomach irritation. This formulation makes ACAMPURE 666 an effective and well-tolerated option for individuals seeking support during alcohol recovery.\n\nACAMPURE 666 should always be used under the supervision of a healthcare professional and is most effective when combined with proper psychological and social support.\n\nComposition\n\nActive Ingredient: Acamprosate Calcium equivalent to Acamprosate 666 mg\n\nDosage Form: Gastro-resistant oral tablet\n\nBrand Name: ACAMPURE 666\n\nEach tablet of ACAMPURE 666 is carefully formulated to deliver a controlled release of Acamprosate in the intestinal tract, helping maintain consistent therapeutic levels in the body.\n\nHow ACAMPURE 666 Works\n\nLong-term alcohol consumption disrupts the balance of certain neurotransmitters in the brain, particularly glutamate and GABA. These chemicals regulate brain activity and mood. When a person stops drinking alcohol, the imbalance may cause symptoms such as anxiety, irritability, insomnia, and strong cravings for alcohol.\n\nACAMPURE 666 works by stabilizing the chemical signaling in the brain. It reduces excessive stimulation caused by glutamate activity and helps normalize brain function after alcohol withdrawal. By restoring this balance, the medication helps reduce cravings and supports abstinence from alcohol.\n\nUnlike some other treatments for alcohol dependence, ACAMPURE 666 does not cause unpleasant reactions if alcohol is consumed. Instead, it works by helping the brain maintain a more stable state that reduces the urge to drink.\n\nUses of ACAMPURE 666\n\nACAMPURE 666 is primarily prescribed to support individuals who have already stopped drinking alcohol and want to maintain long-term sobriety.\n\n1. Maintenance of Alcohol Abstinence\n\nThe primary use of ACAMPURE 666 is to help individuals remain alcohol-free after detoxification. It reduces the mental and emotional urge to drink and strengthens recovery efforts.\n\n2. Support During Alcohol Rehabilitation Programs\n\nACAMPURE 666 is often included as part of structured alcohol rehabilitation programs that include therapy, counseling, and social support.\n\n3. Reduction of Alcohol Cravings\n\nMany individuals in recovery experience persistent cravings that can trigger relapse. ACAMPURE 666 helps reduce these cravings by stabilizing brain chemistry.\n\n4. Long-Term Recovery Support\n\nAlcohol addiction is a long-term condition that may require extended treatment. ACAMPURE 666 can be used for several months or longer as recommended by a healthcare professional to maintain recovery progress.\n\nKey Benefits of ACAMPURE 666\n\nACAMPURE 666 provides several important benefits for individuals recovering from alcohol dependence.\n\nHelps Maintain Sobriety\n\nOne of the most important benefits of ACAMPURE 666 is its ability to help individuals remain alcohol-free. It supports the brain during the recovery process and reduces the risk of relapse.\n\nReduces Alcohol Cravings\n\nThe medication works directly on brain neurotransmitters to reduce the intense cravings that often occur after quitting alcohol.\n\nSupports Brain Recovery\n\nProlonged alcohol consumption affects brain function. ACAMPURE 666 helps restore the natural chemical balance, allowing the brain to gradually recover.\n\nNon-Addictive Treatment Option\n\nACAMPURE 666 is not addictive and does not produce dependency, making it a safe option for long-term use in alcohol recovery programs.\n\nGastro-Resistant Formulation\n\nThe gastro-resistant coating protects the tablet from stomach acid and ensures that the medication is released in the intestine. This improves absorption and reduces stomach irritation.\n\nCompatible with Therapy Programs\n\nACAMPURE 666 works well alongside counseling, behavioral therapy, and support groups, helping patients achieve better recovery outcomes.\n\nRecommended Dosage and Administration\n\nACAMPURE 666 should be taken exactly as prescribed by a healthcare professional.\n\nTypical usage guidelines include:\n\nThe medication is usually taken three times daily.\n\nTablets should be swallowed whole with water.\n\nDo not crush or chew the gastro-resistant tablets.\n\nIt can be taken with or without food.\n\nTreatment often begins after the patient has stopped drinking alcohol.\n\nThe exact dosage and duration of treatment may vary depending on the patient's medical condition and the doctor’s recommendation.\n\nPossible Side Effects of ACAMPURE 666\n\nLike all medications, ACAMPURE 666 may cause side effects in some individuals. Most side effects are mild and tend to improve as the body adjusts to the medication.\n\nCommon Side Effects\n\nDiarrhea\n\nNausea\n\nStomach discomfort\n\nLoss of appetite\n\nHeadache\n\nDizziness\n\nThese symptoms are usually temporary and may disappear with continued use.\n\nLess Common Side Effects\n\nSome individuals may experience:\n\nDry mouth\n\nFatigue\n\nAnxiety or mood changes\n\nSkin rash or itching\n\nDifficulty sleeping\n\nRare but Serious Side Effects\n\nIn rare cases, serious side effects may occur, such as:\n\nSevere allergic reactions\n\nDepression or suicidal thoughts\n\nSignificant changes in mood or behavior\n\nIf any severe symptoms occur, medical attention should be sought immediately.\n\nPrecautions and Safety Information\n\nBefore taking ACAMPURE 666, patients should discuss their medical history and current medications with their healthcare provider.\n\nImportant precautions include:\n\nInform the doctor if you have kidney disease, as dosage adjustments may be required.\n\nACAMPURE 666 should not be used by individuals with severe kidney impairment.\n\nPregnant or breastfeeding women should consult their doctor before using this medication.\n\nPatients should continue participating in counseling or therapy while taking the medication.\n\nAvoid skipping doses to maintain consistent effectiveness.\n\nIt is important to note that ACAMPURE 666 works best for individuals who are committed to remaining alcohol-free.\n\nStorage Instructions\n\nTo maintain the quality and effectiveness of ACAMPURE 666:\n\nStore the tablets at room temperature.\n\nKeep away from direct sunlight and moisture.\n\nStore in the original packaging until use.\n\nKeep out of reach of children.\n\nDo not use the medication after the expiration date mentioned on the packaging.\n\nConclusion\n\nACAMPURE 666 (Acamprosate Gastro-Resistant 666 mg) is an effective medication designed to support individuals recovering from alcohol dependence. By helping restore the natural balance of brain chemicals disrupted by long-term alcohol use, it reduces cravings and supports long-term abstinence.\n\nThe gastro-resistant formulation enhances absorption and minimizes stomach irritation, making it a reliable treatment option in alcohol recovery programs. When combined with counseling, behavioral therapy, and strong social support, ACAMPURE 666 can significantly improve the chances of maintaining sobriety.", "price": 276.0, "discountamount": 83.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2318, "imageuri": "https://productimages.withfloats.com/actual/69abcba0ad5b8f3f9ba860c5.png", "tileimageuri": "https://productimages.withfloats.com/tile/69abcba0ad5b8f3f9ba860c5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-07T06:54:22.273Z", "updatedon": "2026-03-12T08:34:27.928Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//acamprosate-gastro-resistant-666mg/2318", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ACAMPURE 666", "category": "NEUROLOGYRANGE", "tags": [ "acamprosate gastro resistant 666mg tablet uses", "how acamprosate 666mg helps stop drinking", "acamprosate gastro resistant tablets benefits", "acamprosate 666mg dosage guide for alcohol recovery", "acamprosate gastro resistant tablets dosage instructions", "buy acamprosate gastro resistant 666mg tablets online", "acamprosate 666mg price in india", "acamprosate 666mg best price online pharmacy" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6960c83f3056ad8a5a1aecba", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cinnarizine and Domperidone Tablets ", "description": "CLANARIZINE DOM represents an advanced pharmaceutical combination that brings together two potent therapeutic agents—Cinnarizine and Domperidone—in a single convenient tablet formulation. This innovative combination medication addresses multiple aspects of vestibular disorders, motion sickness, and associated nausea and vomiting, providing comprehensive relief for patients suffering from these debilitating conditions. Manufactured under stringent quality control standards, CLANARIZINE DOM offers a synergistic approach to managing symptoms that significantly impact quality of life and daily functioning.The combination of Cinnarizine and Domperidone in CLANARIZINE DOM is based on sound pharmacological principles. While Cinnarizine works primarily on the vestibular system to reduce dizziness and vertigo, Domperidone acts as an effective antiemetic to control nausea and vomiting. Together, these two active ingredients provide more comprehensive symptom control than either agent alone, making CLANARIZINE DOM an excellent choice for patients experiencing vestibular disturbances accompanied by gastrointestinal symptoms.This combination therapy is particularly valuable because vertigo, dizziness, and motion sickness are frequently accompanied by nausea and vomiting. Patients suffering from these conditions often find that addressing only one aspect of their symptoms provides insufficient relief. CLANARIZINE DOM's dual-action formula tackles both the underlying vestibular dysfunction and the accompanying gastrointestinal distress, offering patients a more complete therapeutic solution that improves both comfort and functional capacity.Understanding the Active IngredientsCinnarizine is a calcium channel blocker with specific antihistaminic and vestibular suppressant properties. Unlike systemic calcium channel blockers used for cardiovascular conditions, Cinnarizine selectively acts on the blood vessels in the inner ear and brain, improving blood flow to these areas. This enhanced circulation helps reduce the frequency and severity of vertigo attacks while also preventing motion sickness. Cinnarizine also possesses mild antihistaminic effects that contribute to its anti-nausea properties, though this is not its primary mechanism of action.The medication works by blocking calcium channels in the vestibular system, which helps stabilize the sensory organs responsible for balance. By reducing the excessive stimulation of the vestibular apparatus, Cinnarizine decreases the sensation of spinning or imbalance that characterizes vertigo. Additionally, its vasodilatory effects improve microcirculation in the inner ear, which can be beneficial for conditions where reduced blood flow contributes to symptoms.Domperidone is a peripheral dopamine antagonist that acts primarily as a prokinetic and antiemetic agent. Unlike some antiemetic medications that cross the blood-brain barrier and cause sedation or extrapyramidal side effects, Domperidone works predominantly in the peripheral nervous system. It blocks dopamine receptors in the chemoreceptor trigger zone (CTZ) located outside the blood-brain barrier, effectively preventing nausea and vomiting without causing significant central nervous system effects.Domperidone also enhances gastrointestinal motility by promoting coordinated contractions of the stomach and upper small intestine. This prokinetic effect helps empty the stomach more efficiently, reducing feelings of fullness, bloating, and discomfort that often accompany vestibular disorders. By accelerating gastric emptying, Domperidone also reduces the likelihood of gastroesophageal reflux, which can exacerbate nausea in some patients.The combination of these two medications in CLANARIZINE DOM creates a complementary therapeutic effect. While Cinnarizine addresses the vestibular component of dizziness and vertigo, Domperidone manages the gastrointestinal symptoms that frequently accompany these conditions. This dual approach provides more comprehensive symptom relief and improves overall treatment outcomes compared to monotherapy with either agent alone.Clinical Applications and UsesCLANARIZINE DOM is indicated for a wide range of conditions characterized by vertigo, dizziness, and associated nausea. Understanding these clinical applications helps healthcare providers select appropriate candidates for this combination therapy.Vestibular Disorders: The primary indication for CLANARIZINE DOM includes various vestibular disorders that cause vertigo and imbalance. These conditions include Ménière's disease, benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and labyrinthitis. Patients with these disorders experience episodes of spinning sensation, loss of balance, and often severe nausea. CLANARIZINE DOM helps reduce the frequency and intensity of vertigo attacks while controlling the accompanying gastrointestinal symptoms.Motion Sickness: CLANARIZINE DOM is highly effective for preventing and treating motion sickness, whether related to travel by car, boat, airplane, or amusement park rides. The medication can be taken prophylactically before travel or at the onset of symptoms. The combination is particularly useful for individuals who experience severe nausea and vomiting with motion sickness, as Domperidone provides powerful antiemetic effects that complement Cinnarizine's anti-motion-sickness properties.Migraine-Associated Vertigo: Many patients with migraines experience vestibular symptoms, including dizziness, vertigo, and motion sensitivity, either during migraine attacks or as independent episodes. CLANARIZINE DOM can help manage these vestibular manifestations of migraine, reducing both the vertigo and the nausea that often accompany migraine headaches.Post-Concussion Syndrome: Following head injuries, some patients develop persistent dizziness, balance problems, and nausea as part of post-concussion syndrome. CLANARIZINE DOM may provide symptomatic relief for these patients during their recovery period, though it should be used as part of a comprehensive treatment approach that includes rest, gradual return to activities, and vestibular rehabilitation when appropriate.Cerebrovascular Insufficiency: In older adults with reduced blood flow to the brain, symptoms such as dizziness, vertigo, tinnitus (ringing in the ears), and cognitive difficulties may develop. Cinnarizine's vasodilatory properties can improve cerebral circulation, potentially reducing these symptoms. The addition of Domperidone helps manage any associated nausea.Radiation-Induced or Chemotherapy-Induced Nausea: While not a primary indication, some healthcare providers use CLANARIZINE DOM as adjunctive therapy for patients undergoing cancer treatment who experience both nausea and dizziness. Domperidone's strong antiemetic properties are particularly valuable in this context.Key Benefits of CLANARIZINE DOMThe unique combination of Cinnarizine and Domperidone in CLANARIZINE DOM offers numerous advantages that make it a preferred choice for managing vestibular disorders and associated symptoms.Comprehensive Symptom Control: The primary benefit of CLANARIZINE DOM is its ability to address multiple symptoms simultaneously. Rather than requiring patients to take separate medications for vertigo and nausea, this combination provides unified treatment in a single tablet. This comprehensive approach improves symptom control across the full spectrum of vestibular disorder manifestations, from the spinning sensation to the gastrointestinal distress that often accompanies it.Improved Patient Compliance: Taking multiple medications can be burdensome, particularly for patients who feel dizzy or nauseated. CLANARIZINE DOM simplifies the treatment regimen by combining two medications in one tablet, making it easier for patients to adhere to their prescribed therapy. Better compliance translates to better outcomes, as consistent medication use is essential for managing chronic vestibular conditions.Synergistic Therapeutic Effects: The combination of Cinnarizine and Domperidone creates synergistic effects that enhance overall efficacy. While Cinnarizine reduces vestibular stimulation and improves inner ear blood flow, Domperidone prevents nausea and promotes gastric emptying. This dual action addresses both the cause and consequences of vestibular dysfunction, providing more complete relief than either medication alone.Reduced Central Nervous System Side Effects: Because Domperidone works primarily in the peripheral nervous system rather than crossing the blood-brain barrier extensively, CLANARIZINE DOM causes less sedation and fewer cognitive effects compared to some alternative antiemetic medications. This allows patients to maintain better alertness and function during treatment, which is particularly important for those who need to continue working or performing daily activities.Enhanced Quality of Life: Vertigo and chronic dizziness significantly impair quality of life, limiting mobility, social interactions, and occupational functioning. The nausea and vomiting that accompany these conditions add another layer of disability. By effectively controlling both vestibular and gastrointestinal symptoms, CLANARIZINE DOM helps restore patients' ability to engage in normal activities, improving overall life satisfaction and functional independence.Fast Onset of Action: CLANARIZINE DOM provides relatively rapid symptom relief, with many patients experiencing improvement within 30 minutes to 2 hours after taking the medication. This quick onset is particularly valuable for acute episodes of vertigo or when taking the medication prophylactically before situations that might trigger motion sickness.Suitable for Long-Term Use: For patients with chronic vestibular disorders requiring ongoing treatment, CLANARIZINE DOM is generally safe for extended use when properly monitored by a healthcare provider. The medication maintains its effectiveness over time without significant tolerance development, making it suitable for long-term symptom management.Improved Gastric Emptying: The prokinetic effects of Domperidone benefit not only nausea but also other gastrointestinal symptoms such as early satiety, bloating, and upper abdominal discomfort. Patients with vestibular disorders often develop gastroparesis or delayed gastric emptying secondary to their condition, and Domperidone addresses this issue effectively.Vascular Benefits: Cinnarizine's ability to improve blood flow to the inner ear and brain provides additional benefits beyond symptom control. Enhanced microcirculation may support healing and recovery in conditions where vascular insufficiency contributes to vestibular dysfunction.Side Effects and Safety ConsiderationsLike all medications, CLANARIZINE DOM can cause side effects, though not everyone experiences them. Understanding potential adverse effects helps patients recognize when to seek medical attention and allows healthcare providers to monitor therapy appropriately.Common Side Effects:The most frequently reported side effect of CLANARIZINE DOM is drowsiness or sedation, occurring in approximately 10-20% of patients. This effect is primarily attributable to Cinnarizine's antihistaminic properties. Patients should avoid driving or operating machinery until they know how the medication affects them. Taking the medication at bedtime can minimize daytime drowsiness for some patients.Dry mouth is another common side effect, affecting roughly 10-15% of patients. This occurs due to anticholinergic effects and can be managed by sipping water frequently, chewing sugar-free gum, or using saliva substitutes if severe. Maintaining good oral hygiene is important to prevent dental problems associated with reduced saliva production.Mild gastrointestinal symptoms, including constipation, abdominal discomfort, or changes in bowel habits, may occur. While Domperidone promotes gastric emptying, it can occasionally alter bowel motility. These effects are usually mild and resolve with continued use or dose adjustment.", "price": 55.0, "discountamount": 17.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2271, "imageuri": "https://productimages.withfloats.com/actual/6960c8410b0da405bc908e58.png", "tileimageuri": "https://productimages.withfloats.com/tile/6960c8410b0da405bc908e58.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-09T09:19:59.281Z", "updatedon": "2026-03-12T09:24:10.244Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cinnarizine-and-domperidone-tablets-/2271", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CLANARIZINE DOM", "category": "NEUROLOGY RANGE", "tags": [ "cinnarizine and domperidone tablet uses", "what is cinnarizine & domperidone tablet used for", "cinnarizine domperidone combination medicine benefits", "how cinnarizine domperidone tablet works", "cinnarizine domperidone tablet for vertigo treatment", "cinnarizine domperidone tablet for inner ear problem", "cinnarizine domperidone tablet for balance disorder", "cinnarizine domperidone tablet for travel sickness", "cinnarizine domperidone tablet for gastric nausea", "cinnarizine & domperidone tablet price in india", "cinnarizine domperidone tablet brand name", "cinnarizine domperidone tablet manufacturer in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6958c5905a7ae6137dc2c613", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "iguratimod 25 mg", "description": "Introduction\n\nLiving with chronic joint pain, stiffness, and inflammation can quietly affect every part of daily life—from simple movements like walking and gripping objects to maintaining an active professional and social routine. Autoimmune conditions such as rheumatoid arthritis often progress slowly but steadily, making early and effective treatment essential for long-term joint health and quality of life.\n\nIBRUNITIME 25, containing Iguratimod 25 mg, is a disease-modifying antirheumatic drug (DMARD) developed to address the root cause of inflammatory joint diseases rather than merely masking symptoms. Unlike conventional painkillers that offer temporary relief, IBRUNITIME 25 works at the immune system level to reduce inflammation, slow joint damage, and improve overall physical function.\n\nThis medication is widely prescribed as part of long-term management strategies for inflammatory arthritis, particularly rheumatoid arthritis, helping patients regain mobility, reduce pain, and protect joint structure over time.\n\nComposition\n\nActive Ingredient: Iguratimod 25 mg\n\nBrand Name: IBRUNITIME 25\n\nDosage Form: Oral Tablet\n\nIguratimod is known for its immunomodulatory and anti-inflammatory properties, making it a valuable option in modern rheumatology care.\n\nHow IBRUNITIME 25 Works\n\nIguratimod works differently from standard anti-inflammatory medicines. Instead of only reducing pain signals, it directly influences immune system activity that leads to chronic inflammation.\n\nKey mechanisms include:\n\nSuppression of inflammatory cytokines such as interleukin-6 (IL-6)\n\nReduction of autoantibody production\n\nInhibition of processes that cause joint cartilage and bone damage\n\nBy targeting these underlying mechanisms, IBRUNITIME 25 helps slow disease progression and preserves joint integrity over time.\n\nUses of IBRUNITIME 25\n1. Rheumatoid Arthritis (RA)\n\nThe primary use of IBRUNITIME 25 is in the treatment of rheumatoid arthritis, a chronic autoimmune disorder characterized by joint pain, swelling, stiffness, and progressive joint destruction.\n\n2. Inflammatory Joint Disorders\n\nIBRUNITIME 25 may also be prescribed in other inflammatory joint conditions where immune-mediated inflammation plays a significant role.\n\n3. Combination Therapy\n\nIt is often used alongside other DMARDs such as methotrexate, depending on disease severity and patient response, to enhance treatment outcomes.\n\nKey Benefits of IBRUNITIME 25\n1. Reduces Joint Pain and Swelling\n\nRegular use helps significantly decrease pain, tenderness, and swelling in affected joints, making daily activities more manageable.\n\n2. Improves Joint Mobility\n\nBy controlling inflammation, IBRUNITIME 25 improves flexibility and range of motion, allowing patients to move more comfortably.\n\n3. Slows Disease Progression\n\nUnlike pain relievers, this medication helps slow the progression of rheumatoid arthritis and reduces long-term joint damage.\n\n4. Targets the Root Cause\n\nIBRUNITIME 25 works on immune pathways responsible for chronic inflammation, offering more comprehensive disease control.\n\n5. Enhances Quality of Life\n\nWith better pain control, improved mobility, and reduced stiffness, patients often experience improved physical independence and emotional well-being.\n\n6. Suitable for Long-Term Use\n\nWhen taken under medical supervision, it is designed for long-term disease management rather than short-term symptom relief.\n\nDosage and Administration\n\nThe usual recommended dose is Iguratimod 25 mg, taken once or twice daily, as prescribed by a healthcare professional.\n\nTablets should be swallowed whole with water.\n\nIt can be taken with or after food to minimize stomach discomfort.\n\nDosage duration depends on disease severity, response to treatment, and physician guidance.\n\nImportant: Do not adjust the dose or stop the medication without consulting your doctor, even if symptoms improve.\n\nPossible Side Effects of IBRUNITIME 25\n\nLike all medications, IBRUNITIME 25 may cause side effects, although not everyone experiences them. Most side effects are mild to moderate and manageable with proper medical supervision.\n\nCommon Side Effects\n\nMild stomach discomfort\n\nNausea\n\nDiarrhea\n\nDizziness\n\nHeadache\n\nLess Common Side Effects\n\nElevated liver enzymes\n\nFatigue\n\nSkin rash\n\nLoss of appetite\n\nRare but Serious Side Effects\n\nLiver function abnormalities\n\nSevere allergic reactions\n\nSignificant gastrointestinal issues\n\nPatients are usually advised to undergo periodic blood tests to monitor liver function and overall health during treatment.\n\nPrecautions and Warnings\n\nLiver Health: Patients with existing liver disorders should use IBRUNITIME 25 cautiously and only under medical supervision.\n\nPregnancy and Breastfeeding: Not recommended unless clearly advised by a doctor.\n\nAlcohol Consumption: Excessive alcohol intake should be avoided due to potential liver strain.\n\nInfections: Inform your doctor if you have active or recurrent infections, as immune modulation may affect infection resistance.\n\nDrug Interactions: Always disclose current medications, supplements, or herbal products to your healthcare provider.\n\nWho Should Avoid IBRUNITIME 25?\n\nIndividuals with severe liver disease\n\nPatients with known hypersensitivity to Iguratimod\n\nPregnant or breastfeeding women (unless specifically prescribed)\n\nStorage Instructions\n\nStore at room temperature\n\nKeep away from moisture and direct sunlight\n\nKeep out of reach of children\n\nDo not use after the expiry date\n\nConclusion\n\nIBRUNITIME 25 (Iguratimod 25 mg) represents a modern, targeted approach to managing rheumatoid arthritis and chronic inflammatory joint disorders. By addressing the immune-driven causes of inflammation rather than simply relieving pain, it offers long-term benefits such as reduced joint damage, improved mobility, and enhanced quality of life.\n\nWhen used responsibly under medical supervision, IBRUNITIME 25 can become an essential part of a comprehensive arthritis management plan—helping patients move with confidence, reduce daily discomfort, and regain control over their health journey.\n\nIf you or your patients are seeking a dependable disease-modifying therapy that balances effectiveness with tolerability, IBRUNITIME 25 stands as a reliable and clinically valuable option in rheumatology care.", "price": 308.0, "discountamount": 93.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2260, "imageuri": "https://productimages.withfloats.com/actual/6958c5977b11f839cdd4d298.png", "tileimageuri": "https://productimages.withfloats.com/tile/6958c5977b11f839cdd4d298.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-03T07:30:24.617Z", "updatedon": "2026-05-16T09:01:15.85Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//iguratimod-25-mg/2260", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IBRUNITIME 25", "category": "ORTHOLOGYRANG", "tags": [ "Iguratimod 25 mg Tablets", "Buy Iguratimod 25 mg Tablets Online", "Anti-Rheumatic Medicine Iguratimod 25 mg", "Iguratimod 25 mg DMARD Tablets", "Best Iguratimod Tablets for Rheumatoid Arthritis Treatment", "Iguratimod 25 mg Tablets for Autoimmune Joint Disorders", "Disease Modifying Anti-Rheumatic Drug Iguratimod", "Buy Iguratimod Tablets Online", "Iguratimod Tablets for Chronic Joint Inflammation", "Iguratimod 25 mg Tablets for Arthritis Management", "Advanced Rheumatology Medicine Iguratimod 25 mg", "iguratimod 25 mg", "tab iguratimod 25 mg", "iguratimod 25 mg tablet uses", "iguratimod 25 mg price", "iguratimod 25 mg side effects", "iguratimod 25 mg tab", "iguratimod 25 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694d14f6274fc8b97e9b7120", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mirtazapine 30mg", "description": "MIRTAZPRIME 30 is a pharmaceutical formulation containing Mirtazapine 30mg as per Indian Pharmacopoeia (IP) standards. This prescription medication belongs to a class of drugs known as tetracyclic antidepressants and represents an advanced therapeutic option for individuals struggling with major depressive disorder and related mental health conditions. Manufactured under stringent quality control measures, MIRTAZPRIME 30 offers patients a reliable and effective solution for managing depression while also addressing associated symptoms such as insomnia and anxiety.\nMirtazapine, the active pharmaceutical ingredient in MIRTAZPRIME 30, works through a unique dual mechanism that distinguishes it from other antidepressants. Unlike selective serotonin reuptake inhibitors (SSRIs), mirtazapine enhances the release of both norepinephrine and serotonin in the brain by blocking specific receptors. This innovative approach not only helps alleviate depressive symptoms but also provides sedative effects that can be particularly beneficial for patients experiencing sleep disturbances alongside depression.\nTherapeutic Uses and Applications\nMIRTAZPRIME 30 is primarily indicated for the treatment of major depressive disorder (MDD), a serious mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest in daily activities. The medication has demonstrated significant efficacy in clinical trials, showing improvement in mood, energy levels, and overall quality of life for patients suffering from depression.\nBeyond its primary indication, healthcare providers may prescribe MIRTAZPRIME 30 for various off-label uses based on clinical judgment and patient needs. The medication has shown promise in managing generalized anxiety disorder, where excessive worry and tension interfere with daily functioning. Its sedative properties make it particularly valuable for patients experiencing insomnia related to depression or anxiety, as it can help restore healthy sleep patterns without the need for additional sleep medications.\nThe 30mg dosage strength represents a therapeutic level commonly prescribed for maintenance treatment after initial dose titration. Patients typically begin with lower doses and gradually increase to 30mg as their body adjusts to the medication and their symptoms require more robust management. This dosage provides an optimal balance between therapeutic efficacy and side effect management for many individuals.\nMIRTAZPRIME 30 may also be considered for patients who have not responded adequately to other antidepressant therapies, offering an alternative mechanism of action that can break through treatment-resistant depression. Additionally, its appetite-stimulating effects can be beneficial for patients experiencing significant weight loss due to depression or other medical conditions.\nKey Benefits and Therapeutic Advantages\nThe benefits of MIRTAZPRIME 30 extend beyond simple symptom relief, offering patients a multifaceted approach to mental health recovery. One of the most significant advantages is its relatively rapid onset of action compared to many other antidepressants. While most SSRIs require several weeks to demonstrate meaningful clinical improvement, patients taking mirtazapine often experience some relief from symptoms within one to two weeks, with continued improvement over subsequent weeks.\nThe dual neurotransmitter action of MIRTAZPRIME 30 provides comprehensive coverage of depressive symptoms. By enhancing both serotonergic and noradrenergic neurotransmission, the medication addresses the complex neurochemical imbalances underlying depression more thoroughly than single-mechanism antidepressants. This broader action can result in more complete symptom resolution and better overall outcomes.\nSleep improvement represents another crucial benefit of MIRTAZPRIME 30. The medication's sedative properties, particularly pronounced at lower doses, help patients fall asleep faster and enjoy more restorative sleep throughout the night. This is especially valuable since sleep disturbances are both a symptom and an exacerbating factor in depression. Better sleep quality contributes to improved daytime functioning, energy levels, and emotional regulation.\nUnlike many antidepressants that commonly cause sexual dysfunction, MIRTAZPRIME 30 has a relatively favorable profile in this regard. The medication is less likely to interfere with sexual function, making it an attractive option for patients who have experienced these troublesome side effects with other antidepressants. This characteristic can significantly improve treatment adherence and quality of life.\nThe appetite-stimulating effect, while considered a side effect by some, can be therapeutically beneficial for patients experiencing significant weight loss or poor appetite due to depression. MIRTAZPRIME 30 can help restore healthy eating patterns and reverse the physical decline that often accompanies severe depressive episodes.\nFurthermore, MIRTAZPRIME 30 does not typically cause the gastrointestinal side effects commonly associated with SSRI antidepressants, such as nausea, diarrhea, or stomach upset. This improved gastrointestinal tolerability enhances patient comfort and compliance with treatment regimens.\nPotential Side Effects and Safety Considerations\nWhile MIRTAZPRIME 30 offers numerous therapeutic benefits, patients should be aware of potential side effects that may occur during treatment. Understanding these effects helps patients make informed decisions and enables early identification of any concerning symptoms requiring medical attention.\nThe most commonly reported side effect is drowsiness or sedation, particularly during the initial weeks of treatment. This effect is typically most pronounced during the first few hours after taking the medication, which is why it's generally recommended for evening administration. Patients should exercise caution when driving, operating machinery, or engaging in activities requiring alertness until they understand how the medication affects them personally.\nIncreased appetite and weight gain represent another frequent side effect of MIRTAZPRIME 30. While beneficial for some patients, others may find this effect undesirable. Weight gain typically ranges from moderate to significant and appears to be dose-related. Patients concerned about weight should discuss dietary strategies and exercise plans with their healthcare provider.\nDry mouth is a common anticholinergic side effect that can cause discomfort but is generally manageable through increased fluid intake, sugar-free gum or candy, and good oral hygiene practices. Some patients may also experience dizziness, particularly when standing up quickly, due to the medication's effects on blood pressure regulation.\nConstipation may occur in some patients and can usually be managed through dietary modifications, increased fiber intake, adequate hydration, and regular physical activity. Less commonly, patients might experience confusion, abnormal dreams, or changes in thinking, particularly in older adults who may be more sensitive to the medication's effects.\nSerious side effects, while rare, require immediate medical attention. These include signs of allergic reactions such as rash, itching, swelling, severe dizziness, or difficulty breathing. Agranulocytosis, a dangerous decrease in white blood cells, is an extremely rare but serious complication that manifests as fever, sore throat, or signs of infection. Any unexplained fever or signs of infection should prompt immediate contact with a healthcare provider.\nSerotonin syndrome is another rare but potentially life-threatening condition that can occur when mirtazapine is combined with other medications affecting serotonin levels. Symptoms include agitation, hallucinations, rapid heartbeat, fever, excessive sweating, muscle stiffness, or coordination problems. Patients should inform their healthcare provider about all medications and supplements they are taking to avoid dangerous interactions.\nAbrupt discontinuation of MIRTAZPRIME 30 can lead to withdrawal symptoms, including nausea, anxiety, irritability, and flu-like symptoms. Therefore, any decision to stop the medication should be made in consultation with a healthcare provider who can develop an appropriate tapering schedule.\nImportant Usage Guidelines\nMIRTAZPRIME 30 should always be taken exactly as prescribed by a qualified healthcare professional. The medication is typically administered once daily, preferably in the evening before bedtime due to its sedative effects. Tablets should be swallowed whole with water and can be taken with or without food, though taking them with food may help reduce any stomach upset.\nConsistency in timing is important for maintaining stable blood levels of the medication and optimizing therapeutic effects. Patients should try to take their dose at approximately the same time each evening. If a dose is missed, it should be taken as soon as remembered unless it's close to the time for the next scheduled dose, in which case the missed dose should be skipped rather than doubling up.\nThe full therapeutic benefits of MIRTAZPRIME 30 may take several weeks to manifest. Patients should continue taking the medication as prescribed even if they don't feel immediate improvement. Premature discontinuation is a common reason for treatment failure in depression management.\nRegular follow-up appointments with the prescribing physician are essential for monitoring treatment response, adjusting dosages if necessary, and screening for potential side effects. Patients should maintain open communication with their healthcare team about their symptoms, concerns, and any changes in their condition.\nConclusion\nMIRTAZPRIME 30 represents a valuable therapeutic option in the comprehensive management of major depressive disorder and related conditions. Its unique mechanism of action, combining enhanced noradrenergic and serotonergic neurotransmission with sedative and appetite-stimulating properties, offers distinct advantages for carefully selected patients. The medication's ability to improve both mood symptoms and sleep disturbances makes it particularly useful for patients experiencing depression accompanied by insomnia.\nThe relatively favorable side effect profile, particularly regarding sexual function and gastrointestinal tolerability, enhances patient acceptance and adherence to treatment. While potential side effects such as sedation, increased appetite, and weight gain require monitoring and management, many patients find these effects tolerable compared to the debilitating symptoms of untreated depression.\nSuccess with MIRTAZPRIME 30, as with any antidepressant therapy, depends on proper patient selection, appropriate dosing, regular monitoring, and a comprehensive treatment approach that may include psychotherapy, lifestyle modifications, and social support alongside pharmacological intervention. Patients should work closely with their healthcare providers to optimize treatment outcomes and maintain long-term mental health wellness.\nThe decision to use MIRTAZPRIME 30 should always be made collaboratively between patient and physician, considering individual symptoms, treatment history, coexisting medical conditions, and personal preferences. With proper use under medical supervision, MIRTAZPRIME 30 can be an effective tool in helping patients reclaim their lives from the devastating effects of depression and move toward recovery and renewed well-being.", "price": 262.0, "discountamount": 79.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2254, "imageuri": "https://productimages.withfloats.com/actual/694d14f83d39ca31a28d046b.png", "tileimageuri": "https://productimages.withfloats.com/tile/694d14f83d39ca31a28d046b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-25T10:41:58.966Z", "updatedon": "2026-03-13T07:46:51.004Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mirtazapine-30mg/2254", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MIRTAZPRIME 30", "category": "NEUROLOGYRANGE", "tags": [ "MIRTAZPRIME 30", "Mirtazapine 30mg as per Indian Pharmacopoeia (IP) standards", "managing depression", "insomnia and anxiety.", "depression or anxiety.", "depredepressive episodes.", "helping patients reclaim their lives from the devastating effects of depression." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694cf85408591c1173b54c2f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pregabalin Epalrestat and Methylcobalamin Tablets", "description": "EPSTATE ED represents an advanced pharmaceutical formulation that combines three powerful therapeutic agents: Pregabalin, Epalrestat, and Methylcobalamin. This innovative triple-combination medication is specifically designed to address the complex pathophysiology of diabetic neuropathy and neuropathic pain conditions. By integrating multiple mechanisms of action, EPSTATE ED offers a comprehensive approach to managing nerve-related complications that significantly impact the quality of life for millions of individuals worldwide.\nThe formulation addresses not only the symptomatic relief of neuropathic pain but also targets the underlying metabolic derangements that contribute to nerve damage progression. This multi-pronged therapeutic strategy makes EPSTATE ED particularly valuable for patients who require more than symptomatic management alone.\nUnderstanding the Active Components\nPregabalin: The Neuropathic Pain Modulator\nPregabalin serves as the cornerstone analgesic component in EPSTATE ED. This anticonvulsant medication works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. Through this mechanism, Pregabalin reduces the release of excitatory neurotransmitters including glutamate, norepinephrine, and substance P. This reduction in neurotransmitter release effectively dampens the abnormal neural signaling that characterizes neuropathic pain conditions.\nThe molecule demonstrates excellent bioavailability and rapid absorption, allowing patients to experience relief within a relatively short timeframe. Its efficacy in managing various neuropathic pain syndromes has been extensively documented in clinical trials, establishing it as a first-line agent for diabetic peripheral neuropathy, postherpetic neuralgia, and other chronic neuropathic pain conditions.\nEpalrestat: The Aldose Reductase Inhibitor\nEpalrestat represents a unique addition to the formulation, functioning as a selective aldose reductase inhibitor. In diabetic conditions, excess glucose is converted to sorbitol through the polyol pathway, with aldose reductase serving as the rate-limiting enzyme. The accumulation of sorbitol within nerve cells leads to osmotic stress, depletion of myoinositol, and subsequent nerve dysfunction.\nBy inhibiting aldose reductase, Epalrestat prevents this harmful sorbitol accumulation, thereby addressing one of the fundamental metabolic abnormalities responsible for diabetic neuropathy. This disease-modifying approach distinguishes EPSTATE ED from purely symptomatic treatments. Epalrestat has been particularly well-studied in Asian populations and has demonstrated the ability to improve nerve conduction velocities and reduce subjective neuropathic symptoms over time.\nMethylcobalamin: The Neurotropic Vitamin\nMethylcobalamin, the bioactive form of Vitamin B12, completes the therapeutic triad in EPSTATE ED. Unlike cyanocobalamin, which requires conversion in the body, methylcobalamin is immediately available for utilization in crucial biochemical processes. It plays an indispensable role in myelin synthesis, the protective sheath surrounding nerve fibers that enables proper signal transmission.\nThis coenzyme participates in methionine synthesis and is essential for maintaining the structural and functional integrity of neurons. Methylcobalamin also facilitates nerve regeneration and has demonstrated neuroprotective properties in various experimental models. For patients with diabetic neuropathy, who often exhibit Vitamin B12 deficiency (sometimes exacerbated by metformin therapy), supplementation with methylcobalamin addresses both nutritional deficits and supports nerve health at a fundamental level.\nClinical Applications and Uses\nEPSTATE ED is primarily indicated for the comprehensive management of diabetic peripheral neuropathy, a condition affecting approximately 50% of individuals with long-standing diabetes. The symptoms of this condition range from tingling sensations and burning pain to numbness and loss of protective sensation, which can lead to serious complications including foot ulcers and amputations.\nBeyond diabetic neuropathy, EPSTATE ED may be prescribed for various neuropathic pain syndromes where the combination of pain relief, metabolic correction, and nerve support proves beneficial. Patients experiencing chronic nerve pain resulting from metabolic disturbances, nutritional deficiencies, or structural nerve damage may find this combination particularly effective.\nThe medication is typically recommended for adults who have not achieved adequate symptom control with single-agent therapy or who would benefit from the synergistic effects of the three components. Healthcare providers may prescribe EPSTATE ED when a patient requires both immediate symptom relief and long-term disease modification.\nKey Benefits and Therapeutic Advantages\nComprehensive Multi-Mechanism Action\nThe primary advantage of EPSTATE ED lies in its multi-faceted approach to neuropathic conditions. Rather than addressing only pain symptoms, the formulation simultaneously tackles pain perception, underlying metabolic abnormalities, and nutritional support for nerve health. This comprehensive strategy may lead to superior outcomes compared to monotherapy approaches.\nEnhanced Pain Relief\nClinical evidence supporting Pregabalin's efficacy in neuropathic pain is substantial. Patients often report significant reductions in pain intensity, improved sleep quality due to decreased nocturnal pain, and enhanced ability to perform daily activities. The pain-relieving effects typically manifest within the first week of therapy and continue to improve with ongoing treatment.\nDisease Modification Potential\nUnlike purely symptomatic treatments, the inclusion of Epalrestat provides genuine disease-modifying potential. By targeting the polyol pathway, EPSTATE ED may slow the progression of nerve damage in diabetic patients. Long-term use may preserve nerve function and prevent the worsening of neuropathic symptoms, offering hope beyond mere symptom management.\nImproved Nerve Conduction and Function\nThe combination of metabolic correction through Epalrestat and neurotropic support via Methylcobalamin creates an environment conducive to nerve regeneration and functional improvement. Studies have demonstrated improvements in nerve conduction velocity parameters with similar combination therapies, suggesting potential restoration of nerve function rather than simple symptom masking.\nConvenience of Combination Therapy\nFor patients who would otherwise require multiple separate medications, EPSTATE ED offers the convenience of a single tablet containing all three therapeutic agents. This simplification of medication regimens improves compliance, reduces pill burden, and may enhance overall treatment outcomes.\nQuality of Life Enhancement\nThe cumulative effect of pain reduction, improved nerve function, and better metabolic control translates into meaningful quality of life improvements. Patients report better mobility, reduced interference of pain with daily activities, improved mood, and enhanced social functioning.\nPotential Side Effects and Safety Considerations\nCommon Side Effects\nAs with any pharmaceutical agent, EPSTATE ED may produce certain adverse effects. The most commonly reported side effects are primarily attributable to the Pregabalin component and include dizziness, somnolence, peripheral edema, dry mouth, blurred vision, weight gain, and difficulty with concentration or attention. These effects are generally mild to moderate and often diminish with continued therapy as the body adapts to the medication.\nGastrointestinal symptoms such as constipation or nausea may occur, though they are typically manageable with dietary modifications or symptomatic treatment. Some patients experience increased appetite leading to weight gain, which requires monitoring, particularly in diabetic individuals where weight management is crucial.\nSerious but Rare Adverse Events\nThough uncommon, certain serious adverse effects warrant immediate medical attention. These include allergic reactions manifesting as rash, itching, swelling, severe dizziness, or breathing difficulties. Pregabalin has been associated with rare cases of angioedema, which requires prompt discontinuation and medical intervention.\nMental health changes, including mood alterations, anxiety, depression, agitation, or suicidal thoughts, have been reported with Pregabalin use, particularly in individuals with pre-existing psychiatric conditions. Patients and caregivers should remain vigilant for behavioral changes and report them immediately to healthcare providers.\nDrug Interactions and Precautions\nEPSTATE ED may interact with other central nervous system depressants, including alcohol, opioids, benzodiazepines, and antihistamines, potentially intensifying sedation and cognitive impairment. Patients should inform their healthcare provider of all medications, supplements, and substances they consume.\nIndividuals with kidney impairment require dose adjustments since Pregabalin is primarily eliminated through renal excretion. Regular monitoring of renal function may be necessary during long-term therapy.\nSpecial Population Considerations\nPregnant or breastfeeding women should use EPSTATE ED only when clearly necessary and under strict medical supervision, as the safety profile in these populations has not been fully established. Elderly patients may be more susceptible to side effects, particularly dizziness and confusion, necessitating careful dose titration and monitoring.\nPatients should be advised against abrupt discontinuation of EPSTATE ED, as sudden cessation of Pregabalin may precipitate withdrawal symptoms including insomnia, nausea, headache, anxiety, and sweating. Gradual dose reduction under medical supervision is recommended when discontinuing therapy.\nDosage and Administration Guidelines\nThe appropriate dosage of EPSTATE ED is highly individualized and should be determined by a qualified healthcare professional based on the patient's specific condition, response to therapy, and tolerance. Typically, treatment begins with a lower dose that is gradually increased to achieve optimal therapeutic benefit while minimizing adverse effects.\nPatients should take EPSTATE ED exactly as prescribed, with or without food, at consistent times each day to maintain stable blood levels. Missing doses should be addressed by taking the forgotten dose as soon as remembered, unless it's nearly time for the next scheduled dose. Double dosing to compensate for missed doses is not recommended.\nRegular follow-up appointments allow healthcare providers to assess treatment efficacy, monitor for adverse effects, and make necessary dose adjustments. Patients should maintain open communication with their medical team regarding symptom improvement, side effects, and any concerns that arise during therapy.\nPatient Counseling and Lifestyle Recommendations\nMaximizing the benefits of EPSTATE ED extends beyond simply taking the medication. Patients should be counseled on complementary lifestyle measures that support neuropathy management. Maintaining optimal glycemic control remains paramount for diabetic patients, as blood sugar management directly impacts neuropathy progression regardless of medication.\nRegular physical activity, within individual capabilities, promotes circulation, supports nerve health, and may enhance the therapeutic effects of EPSTATE ED. Daily foot examinations become critical for diabetic patients to identify potential injuries early, preventing serious complications.\nNutritional optimization, including adequate intake of B vitamins, antioxidants, and essential nutrients, supports the neurotropic effects of Methylcobalamin. Avoiding alcohol and tobacco, both of which can exacerbate neuropathy, is strongly recommended.\nPatients should be cautioned about activities requiring alertness, such as driving or operating machinery, especially during the initial treatment phase when dizziness and somnolence may be more pronounced. These effects typically improve with continued therapy, but individual responses vary.\nConclusion\nEPSTATE ED represents a thoughtfully designed pharmaceutical formulation that addresses the multifaceted nature of diabetic neuropathy and neuropathic pain through its unique combination of Pregabalin, Epalrestat, and Methylcobalamin. This triple-action approach offers patients more than symptomatic relief—it provides genuine disease modification potential, nutritional support, and comprehensive nerve health optimization.\nThe synergistic effects of these three components create a therapeutic profile that is greater than the sum of its parts. While Pregabalin efficiently manages pain symptoms and improves quality of life in the short term, Epalrestat works to address underlying metabolic derangements that drive disease progression, and Methylcobalamin provides essential neurotropic support for nerve regeneration and function.\nFor patients struggling with the debilitating effects of neuropathic pain and diabetic neuropathy, EPSTATE ED offers renewed hope for better symptom control and potentially slowed disease progression. The convenience of combination therapy in a single tablet improves adherence and simplifies complex treatment regimens.\nHowever, EPSTATE ED is not without considerations. Potential side effects, though generally manageable, require awareness and monitoring. The medication is most effective when integrated into a comprehensive management plan that includes optimal glycemic control, lifestyle modifications, and regular medical supervision.\nUltimately, EPSTATE ED should be viewed as a valuable tool in the therapeutic arsenal against neuropathic conditions, best utilized under the guidance of knowledgeable healthcare professionals who can individualize treatment to each patient's unique needs and circumstances. With proper use, monitoring, and patient education, EPSTATE ED can significantly improve outcomes and quality of life for those affected by these challenging neurological conditions.", "price": 275.0, "discountamount": 82.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2253, "imageuri": "https://productimages.withfloats.com/actual/694cf859d25fa0b0657b1ac8.png", "tileimageuri": "https://productimages.withfloats.com/tile/694cf859d25fa0b0657b1ac8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-25T08:39:48.947Z", "updatedon": "2026-04-18T09:21:49.885Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pregabalin-epalrestat-and-methylcobalamin-tablets/2253", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EPSTATE ED", "category": "NEUROLOGYRANGE", "tags": [ "regabalin, Epalrestat, and Methylcobalamin.neuropathic pain conditions.", "Pregabalin, Epalrestat, and Methylcobalamin.", "neuropathic pain.", "diabetic neuropathy.", "sorbitol within nerve cells leads to osmotic stress.", "Epalrestat and neurotropic support via Methylcobalamin creates an environment .", "mood alterations, anxiety, depression, agitation.", "supports the neurotropic effects of Methylcobalamin.", "Pregabalin Epalrestat and Methylcobalamin Tablets", "epalrestat and methylcobalamin tablets uses", "epalrestat and methylcobalamin tablets in hindi", "pregabalin epalrestat and methylcobalamin tablets price jaipur", "pregabalin epalrestat and methylcobalamin tablets price india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "imatinib 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2026-04-15T10:27:12.329Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imatinib-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy.", "imatinib 400mg.", "imatinib 400mg tablet.", "tab. imatinib 400mg.", "imatinib 400mg price.", "imatinib 400mg tab", "imatinib 400mg side effects.", "imatinib 400 mg tablet", "imatinib 400 mg medicine", "imatinib tablets 400 mg uses", "imatinib 400 mg dosage", "imatinib 400 mg price in india", "imatinib 400 mg brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ae3f4b453b6167c50636f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE 50 ", "description": "QT-PINE 50 \nQuetiapine (50mg)\nIntroduction:\nQT-PINE 50 encapsulates the therapeutic prowess of Quetiapine, an esteemed atypical antipsychotic renowned for its efficacy in managing a spectrum of psychiatric conditions. With a dosage strength of 50mg, QT-PINE 50 aims to harmonize mental health by addressing specific symptoms and promoting stability.\nKey Features and Benefits:\n\nAntipsychotic Efficacy:\n\nQuetiapine, the cornerstone of QT-PINE 50, exerts its antipsychotic effects by modulating dopamine and serotonin receptors, alleviating symptoms like hallucinations, delusions, and cognitive distortions in conditions such as schizophrenia.\nMood Stabilization:\n\nQT-PINE 50 aids in stabilizing mood fluctuations associated with bipolar disorder, helping to mitigate manic and depressive episodes and fostering emotional equilibrium.\nDepression Management:\n\nBeyond its antipsychotic properties, Quetiapine in QT-PINE 50 exhibits antidepressant effects by enhancing serotonin and norepinephrine activity, making it beneficial for individuals grappling with major depressive disorder (MDD).\nAnxiolytic Support:\n\nQT-PINE 50's anxiolytic attributes contribute to reducing anxiety symptoms prevalent in generalized anxiety disorder (GAD) and social anxiety disorder (SAD), promoting a sense of calmness and composure.\nDosage and Administration:\n\nInitiation and Adjustment:\nThe recommended starting dose of QT-PINE 50 is 50mg administered orally once daily. Dosage adjustments should be made judiciously under medical supervision based on individual response and tolerability.\nAdministration Guidance:\nQT-PINE 50 tablets should be swallowed whole with water, not crushed or chewed, and taken consistently at the same time daily for optimal therapeutic outcomes.\nTreatment Duration:\nContinuation of QT-PINE 50 should align with healthcare provider recommendations, even if symptom improvement is noted, to sustain therapeutic benefits and prevent relapse.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW .", "price": 51.0, "discountamount": 15.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SAD", "GAD", "MDD", "50mg", "EMAIL", "manic", "sense", "water", "product", "relapse", "dopamine", "spectrum", "calmness", "delusions", "composure", "stability", "same time", "Initiation", "Quetiapine", "individuals", "cornerstone", "information", "Introduction", "sterisonline", "sterispharma", "Continuation", "tolerability", "Key Features", "schizophrenia", "mental health", "starting dose", "CALL/WHATSAPP", "hallucinations", "dosage strength", "QT-PINE 50 aids", "bipolar disorder", "anxiety symptoms", "specific symptoms", "mood fluctuations", "Treatment Duration", "Dosage adjustments", "Anxiolytic Support", "Mood Stabilization", "QT-PINE 50 tablets", "serotonin receptors", "therapeutic prowess", "depressive episodes", "symptom improvement", "individual response", "medical supervision", "therapeutic benefits", "antipsychotic effects", "anxiolytic attributes", "Depression Management", "emotional equilibrium", "cognitive distortions", "psychiatric conditions", "Antipsychotic Efficacy", "antidepressant effects", "atypical antipsychotic", "norepinephrine activity", "social anxiety disorder", "Administration Guidance", "antipsychotic properties", "major depressive disorder", "optimal therapeutic outcomes", "generalized anxiety disorder", "healthcare provider recommendations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1886, "imageuri": "https://productimages.withfloats.com/actual/667d1603c134db5b38ba48f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d1603c134db5b38ba48f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:20:04.778Z", "updatedon": "2026-03-14T10:28:17.931Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//qt-pine-50-/1886", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "QT-PINE 50 ", "category": "NEUROLOGY RANGE", "tags": [ "quetiapine 50 mg uses", "quetiapine side effects", "QT-PINE 50", "", "quetiapine for sleep", "quetiapine for sleep side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }